First human test for new hope against tough blood cancers
NCT ID NCT07255898
Summary
This is a first-in-human study to test the safety and initial effects of a new drug called BL-M24D1. It is for adults with advanced multiple myeloma or other blood cancers that have come back or stopped responding to standard treatments. The main goals are to find a safe dose and see how the body processes the drug.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
West China Hospital of Sichuan University
Chengdu, Sichuan, China
Contact
Conditions
Explore the condition pages connected to this study.